Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Silent atrial fibrillation detected by home-monitoring: Cardiovascular disease and stroke prevention in patients with diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

APA

CBE

MLA

Vancouver

Author

Højager, Anna ; Tingsgaard, Jakob K ; Andersen, Ditte ; Søholm, Helle ; Taskiran, Mustafa ; Bock, Troels G ; Schoos, Mikkel M. / Silent atrial fibrillation detected by home-monitoring : Cardiovascular disease and stroke prevention in patients with diabetes. In: Journal of Diabetes and its Complications. 2020 ; Vol. 34, No. 12. pp. 107711.

Bibtex

@article{e355820dc867469eb8649e014d7b31f2,
title = "Silent atrial fibrillation detected by home-monitoring: Cardiovascular disease and stroke prevention in patients with diabetes",
abstract = "Objective: Patients with silent and undiagnosed paroxysmal atrial fibrillation and flutter (AF) have increased risk of ischemic stroke. Patients with diabetes have a higher risk of both AF and ischemic stroke compared to patients without diabetes. Our aim was to investigate the prevalence of silent AF in patients with diabetes in an outpatient cohort and to identify the possible risk factors associated with AF. Research design and methods: This prospective observational study was performed in the outpatient diabetes clinic at a single University Hospital. We included 217 patients with type 1 or type 2 diabetes with at least one additional risk factor from the CHA 2DS 2VASc Score for Stroke Risk Assessment in Atrial Fibrillation. The primary outcome was prevalence of AF, with a duration of at least 30 s, recorded by a seven-day home-monitor, external loop recorder (ELR) in comparison to a standard resting ECG. Seventeen patients were excluded due to premature removal of the device. Results: In the final cohort of 200 patients the majority were male (58.5%) with a mean age of 66 ± 0.7 years. The mean BMI was 29 ± 6 and patients had a mean diabetes history of 23 ± 14 years with the majority diagnosed with type 2 diabetes (59%). Comorbidity was common with hypertension in 86%, and dyslipidemia in 80%. The total prevalence of silent AF [n = 20 (10%)] or flutter [n = 1 (0.5%)] was 10.5% using the ELR compared to a 0.0% detection-rate in the standard ECG method (p < 0.001). Higher age, male gender, albuminuria, and elevated systolic blood pressure were associated with AF in univariate analyses, but only age [OR 1.14 (95% CI = 1.00–2.04) (p = 0.048)], male gender [OR 4.9 (95% CI = 1.30–18.65) (p = 0.019)] and albuminuria [OR 2.7 (95% CI =1.08–6.98) (p = 0.034) were independently associated with AF. Mean CHA 2DS 2VASc Score was ≥2 (4.1, SD ± 1.6), and patients with AF were referred to further cardiac evaluation. Conclusion: Undiagnosed, silent AF is common in high-risk cohort with a long history of diabetes followed in a University Hospital outpatient clinic. Non-invasive monitoring with ELR enhances detection of AF and identifies candidates for early anticoagulation treatment with the possible effect of stroke prevention. ",
keywords = "Atrial fibrillation, Diabetes mellitus, Hypertension, Outpatient care, Stroke-prevention",
author = "Anna H{\o}jager and Tingsgaard, {Jakob K} and Ditte Andersen and Helle S{\o}holm and Mustafa Taskiran and Bock, {Troels G} and Schoos, {Mikkel M}",
note = "Copyright {\textcopyright} 2020 Elsevier Inc. All rights reserved.",
year = "2020",
month = dec,
day = "1",
doi = "10.1016/j.jdiacomp.2020.107711",
language = "English",
volume = "34",
pages = "107711",
journal = "Journal of Diabetes and its Complications",
issn = "1056-8727",
publisher = "Elsevier Inc",
number = "12",

}

RIS

TY - JOUR

T1 - Silent atrial fibrillation detected by home-monitoring

T2 - Cardiovascular disease and stroke prevention in patients with diabetes

AU - Højager, Anna

AU - Tingsgaard, Jakob K

AU - Andersen, Ditte

AU - Søholm, Helle

AU - Taskiran, Mustafa

AU - Bock, Troels G

AU - Schoos, Mikkel M

N1 - Copyright © 2020 Elsevier Inc. All rights reserved.

PY - 2020/12/1

Y1 - 2020/12/1

N2 - Objective: Patients with silent and undiagnosed paroxysmal atrial fibrillation and flutter (AF) have increased risk of ischemic stroke. Patients with diabetes have a higher risk of both AF and ischemic stroke compared to patients without diabetes. Our aim was to investigate the prevalence of silent AF in patients with diabetes in an outpatient cohort and to identify the possible risk factors associated with AF. Research design and methods: This prospective observational study was performed in the outpatient diabetes clinic at a single University Hospital. We included 217 patients with type 1 or type 2 diabetes with at least one additional risk factor from the CHA 2DS 2VASc Score for Stroke Risk Assessment in Atrial Fibrillation. The primary outcome was prevalence of AF, with a duration of at least 30 s, recorded by a seven-day home-monitor, external loop recorder (ELR) in comparison to a standard resting ECG. Seventeen patients were excluded due to premature removal of the device. Results: In the final cohort of 200 patients the majority were male (58.5%) with a mean age of 66 ± 0.7 years. The mean BMI was 29 ± 6 and patients had a mean diabetes history of 23 ± 14 years with the majority diagnosed with type 2 diabetes (59%). Comorbidity was common with hypertension in 86%, and dyslipidemia in 80%. The total prevalence of silent AF [n = 20 (10%)] or flutter [n = 1 (0.5%)] was 10.5% using the ELR compared to a 0.0% detection-rate in the standard ECG method (p < 0.001). Higher age, male gender, albuminuria, and elevated systolic blood pressure were associated with AF in univariate analyses, but only age [OR 1.14 (95% CI = 1.00–2.04) (p = 0.048)], male gender [OR 4.9 (95% CI = 1.30–18.65) (p = 0.019)] and albuminuria [OR 2.7 (95% CI =1.08–6.98) (p = 0.034) were independently associated with AF. Mean CHA 2DS 2VASc Score was ≥2 (4.1, SD ± 1.6), and patients with AF were referred to further cardiac evaluation. Conclusion: Undiagnosed, silent AF is common in high-risk cohort with a long history of diabetes followed in a University Hospital outpatient clinic. Non-invasive monitoring with ELR enhances detection of AF and identifies candidates for early anticoagulation treatment with the possible effect of stroke prevention.

AB - Objective: Patients with silent and undiagnosed paroxysmal atrial fibrillation and flutter (AF) have increased risk of ischemic stroke. Patients with diabetes have a higher risk of both AF and ischemic stroke compared to patients without diabetes. Our aim was to investigate the prevalence of silent AF in patients with diabetes in an outpatient cohort and to identify the possible risk factors associated with AF. Research design and methods: This prospective observational study was performed in the outpatient diabetes clinic at a single University Hospital. We included 217 patients with type 1 or type 2 diabetes with at least one additional risk factor from the CHA 2DS 2VASc Score for Stroke Risk Assessment in Atrial Fibrillation. The primary outcome was prevalence of AF, with a duration of at least 30 s, recorded by a seven-day home-monitor, external loop recorder (ELR) in comparison to a standard resting ECG. Seventeen patients were excluded due to premature removal of the device. Results: In the final cohort of 200 patients the majority were male (58.5%) with a mean age of 66 ± 0.7 years. The mean BMI was 29 ± 6 and patients had a mean diabetes history of 23 ± 14 years with the majority diagnosed with type 2 diabetes (59%). Comorbidity was common with hypertension in 86%, and dyslipidemia in 80%. The total prevalence of silent AF [n = 20 (10%)] or flutter [n = 1 (0.5%)] was 10.5% using the ELR compared to a 0.0% detection-rate in the standard ECG method (p < 0.001). Higher age, male gender, albuminuria, and elevated systolic blood pressure were associated with AF in univariate analyses, but only age [OR 1.14 (95% CI = 1.00–2.04) (p = 0.048)], male gender [OR 4.9 (95% CI = 1.30–18.65) (p = 0.019)] and albuminuria [OR 2.7 (95% CI =1.08–6.98) (p = 0.034) were independently associated with AF. Mean CHA 2DS 2VASc Score was ≥2 (4.1, SD ± 1.6), and patients with AF were referred to further cardiac evaluation. Conclusion: Undiagnosed, silent AF is common in high-risk cohort with a long history of diabetes followed in a University Hospital outpatient clinic. Non-invasive monitoring with ELR enhances detection of AF and identifies candidates for early anticoagulation treatment with the possible effect of stroke prevention.

KW - Atrial fibrillation

KW - Diabetes mellitus

KW - Hypertension

KW - Outpatient care

KW - Stroke-prevention

UR - http://www.scopus.com/inward/record.url?scp=85090306443&partnerID=8YFLogxK

U2 - 10.1016/j.jdiacomp.2020.107711

DO - 10.1016/j.jdiacomp.2020.107711

M3 - Journal article

C2 - 32900590

VL - 34

SP - 107711

JO - Journal of Diabetes and its Complications

JF - Journal of Diabetes and its Complications

SN - 1056-8727

IS - 12

M1 - 107711

ER -

ID: 60818452